Serum anti-recoverin antibodies is found in elderly patients with retinitis pigmentosa and cancer.
Taimu SatoKoji Miura NishiguchiKosuke FujitaFuyuki MiyaTakashi InoueErika SasakiToshifumi AsanoSatoru TsudaYukihiro ShigaHiroshi KunikataMitsuru NakazawaToru NakazawaPublished in: Acta ophthalmologica (2020)
Our results show that serum anti-recoverin antibodies can be detected in typical RP patients with identified pathogenic mutations and that a history of cancer may increase the risk of developing anti-recoverin antibodies.